The latest advances in hormonal contraception

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 37, Issue 3, 2008, Pages 369-374

  Fontenot, Holly B ^a   Harris, Allyssa L ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Birth control; Contraception; Family planning; Hormones

Indexed keywords

EID: 44649138581     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2008.00248.x     Document Type: Article

References (31)

1. Abma, J., Martinez, G., Mosher, W., & Dawson, B. (2004). Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2002. Washington, DC: National Centers for Health Statistics, Vital and Health Statistics, 23 (24). Retrieved January 2, 2007, from www.cdc.gov/nchs.nsfg.htm
2. Alan Guttmacher Institute. (2005). Facts in brief: Contraceptive use. New York: Author.
3. Archer, D., Jensen, J., Johnson, J. Borisute, H., Grubb, G., & Constantine, G. (2006). Evaluation of continuous regimen of levonorgestrel/ethinyl estradiol: Phase 3 study results. Contraception, 74, 439-445.
4. Arias, R., Kaunitz, A., & McClung, M. (2007). Depot medroxyprogesterone acetate and bone density. Dialogues in Contraception, 11(1), 1-12.
5. Aschenbrenner, D. (2006). Over-the-counter access to emergency contraception. American Journal of Nursing, 106(11), 34-36.
6. Barreiros, F. A., Guazzelli, C. A. F., de Araujo, F. F., & Barbosa, R. (2007). Bleeding patterns of women using extended regimens of the contraceptive vaginal ring. Contraception, 75, 204-208.
7. Batur, P., Elder, J. & Mayer, M. (2003). Update on contraception: Benefits and risks of the new formulations. Cleveland Clinic Journal of Medicine, 70, 681-696.
8. Connell, E. (1999). Contraception in the pre pill era. Contraception, 59, 7S-10S.
9. Dickey, R. (2006). Managing contraceptive pill patients (13th ed.). Dallas, TX: EMIS Medical Publishers.
10. Dieben, T., Roumen, F., & Apter, D. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstetrics and Gynecology, 100, 585-593.
11. Finer, L., & Henshaw, S. (2006). Disparities in rates of unintended pregnancy in the United States, 1994-2001. Perspectives on Sexual and Reproductive Health, 38, 90-96.
12. Food and Drug Administration. (2004). Black box warning added concerning long- term use of Depo Provera contraceptive injection. Retrieved July 17, 2007, from www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html.
13. Kaplan, C. (2006). Special issues in contraception: Caring for women with disabilities. Journal of Midwifery & Women's Health, 51, 450-456.
14. London, A. (2007). Bleeding and cycle control with the newer oral contraceptive formulations. Female Patient (April supplement.) 32(4), 1-4.
15. Masimasi, N., Sivanandy, M., & Thacker, H. (2007). Update on hormonal contraception. Cleveland Clinic Journal of Medicine, 74, 186-198.
16. Miller, L., & Hughes, J. (2003). Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: A randomized trial. American Journal of Obstetrics & Gynecology, 101, 653-661.
17. Mosher, W., Martinez, G., Chandra, A., Abma, J., & Wilson, S. (2004). Use of contraception and use of family planning services in the United States: 1982-2002 (Advanced Data No. 350). Atlanta, GA: National Center for Health Statistics.
18. Nakajima, S. T., Archer, D. F., & Ellman, H. (2007). Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 ug (Loestrin24® Fe). Contraception, 75, 16-22.
19. Nelson, A., & Sulak, P. (2006). New approaches in oral contraceptive regimes: Breaking out of old models. Forum, 4(2), 2-5.
20. Ngai, S. W., Fan, S., Li, S., Cheng, L., Ding, J. Jing, X., et al. (2004). A randomized trial to compare 24h versus 12h double dose regimen of levonorgestrel for emergency contraception. Human Reproduction, 20, 307-311.
21. Okewole, I. A., Arowojolu, A. O., Odusoga, O. L., Oloyede, O. A., Adeleye, O. A., Salu, J., et al. (2007). Effect of single administration of levonorgestrel on the menstrual cycle. Contraception, 75, 372-377.
22. Pfizer, Inc. (2005). Depo-subQ Provera 104. Retrieved May 28, 2007, from http://www.depo-subqprovera104.com/lesshormone.aspx.
23. Reuters Health Information. (2006). Schering says FDA approves drug to treat PMDD. Retrieved January 3, 2007, from www.medscape.com/viewarticle/ 545648.html.
24. Robinson, K. (2005). Depo-Provera: New concerns-same issues? AWHONN Lifelines, 9, 214-217.
25. Schnare, S. (2006). Introducing a unique combined oral contraceptive formulation. American Journal for Nurse Practitioners, 10(9), 71-78.
26. Scholes, D., LaCroix, A., Ichikawa, L., Barlow, W., & Ott, S. (2005). Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Archives in Pediatric Adolescent Medicine, 159, 139-144.
27. Steinauer, J. (2005). A new era of contraception. Advanced Studies in Medicine, 5, 285-293.
28. Trussell, J., & Jordan, B. (2006). Editorial: Mechanism of action of emergency contraceptive pills. Contraception, 74, 87-89.
29. Tyrer, L. (1999). Introduction of the pill and its impact. Contraception, 59, 11s-16s.
30. World Health Organization. (2002). Developing new methods of fertility. Retrieved July 18, 2007, from www.who.int/reproductive-health/ publications/biennial_reports/1994-95/7.html.
31. Wysocki, S. (2007). Clinical rationale for continuous oral contraception. American Journal for Nurse Practitioners, 11(3), 57-67.